Search research articles
Contact Us
Filters
Showing results (601-610 of 821) with videos related to
Page
of 83
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
January 1, 1995
An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin
M Manning, L L Cheng, S Stoev, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
November 20, 2013
Decline in ACEI/ARB Prescribing as Heart Failure Core Metrics Improve During Computer-Based Clinical Decision Support
Pedro J Caraballo, James M Naessens, Mark J Klarich, et al.
Biochemistry
|
January 24, 1989
Activity and spectroscopic properties of bacterial D-amino acid transaminase after multiple site-directed mutagenesis of a single tryptophan residue
A Martínez del Pozo, M Merola, H Ueno, et al.
The Quarterly Journal of Medicine
|
January 1, 1982
Long-term experience of alfacalcidol in renal osteodystrophy
V L Sharman, A M Brownjohn, F J Goodwin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 21, 2000
The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis
D M Gerlag, L Ransone, P P Tak, et al.
European Journal of Biochemistry
|
June 24, 2000
Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding
N Cotte, M N Balestre, A Aumelas, et al.
Nature
|
December 22, 1998
Identification of the receptor component of the IkappaBalpha-ubiquitin ligase
A Yaron, A Hatzubai, M Davis, et al.
AIDS (London, England)
|
March 17, 2023
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV
Felicia L Sterman, Jacob P Lalezari, Ula M Kowalczyk, et al.
Mayo Clinic Proceedings
|
February 14, 2021
Predicting Delirium Risk Using an Automated Mayo Delirium Prediction Tool: Development and Validation of a Risk-Stratification Model
Sandeep R Pagali, Donna Miller, Karen Fischer, et al.
Journal of Medicinal Chemistry
|
February 1, 1989
Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin
M Manning, M Kruszynski, K Bankowski, et al.
Page
of 83
Search research articles
Search
Showing results (601-610 of 821) with videos related to
Sort By:
Page
of 83
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
January 1, 1995
An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin
M Manning, L L Cheng, S Stoev, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
November 20, 2013
Decline in ACEI/ARB Prescribing as Heart Failure Core Metrics Improve During Computer-Based Clinical Decision Support
Pedro J Caraballo, James M Naessens, Mark J Klarich, et al.
Biochemistry
|
January 24, 1989
Activity and spectroscopic properties of bacterial D-amino acid transaminase after multiple site-directed mutagenesis of a single tryptophan residue
A Martínez del Pozo, M Merola, H Ueno, et al.
The Quarterly Journal of Medicine
|
January 1, 1982
Long-term experience of alfacalcidol in renal osteodystrophy
V L Sharman, A M Brownjohn, F J Goodwin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 21, 2000
The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis
D M Gerlag, L Ransone, P P Tak, et al.
European Journal of Biochemistry
|
June 24, 2000
Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding
N Cotte, M N Balestre, A Aumelas, et al.
Nature
|
December 22, 1998
Identification of the receptor component of the IkappaBalpha-ubiquitin ligase
A Yaron, A Hatzubai, M Davis, et al.
AIDS (London, England)
|
March 17, 2023
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV
Felicia L Sterman, Jacob P Lalezari, Ula M Kowalczyk, et al.
Mayo Clinic Proceedings
|
February 14, 2021
Predicting Delirium Risk Using an Automated Mayo Delirium Prediction Tool: Development and Validation of a Risk-Stratification Model
Sandeep R Pagali, Donna Miller, Karen Fischer, et al.
Journal of Medicinal Chemistry
|
February 1, 1989
Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin
M Manning, M Kruszynski, K Bankowski, et al.
Page
of 83